Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
1.250
-0.240 (-16.11%)
Oct 13, 2026, 2:57 PM EDT - Market open
Silo Pharma Employees
Silo Pharma had 3 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Silo Pharma the 42,902nd largest employer in the world and 7,001st in the United States.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$18,026
Profits / Employee
-$1,490,638
Market Cap
1.99M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 3 | 0 | - |
| Dec 31, 2024 | 3 | 0 | - |
| Dec 31, 2023 | 3 | 0 | - |
| Dec 31, 2022 | 3 | 1 | 50.00% |
| Dec 31, 2021 | 2 | 1 | 100.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Jaguar Health | 47 |
| PMGC Holdings | 34 |
| GeoVax Labs | 19 |
| BioRestorative Therapies | 14 |
| Genprex | 13 |
| Kairos Pharma | 4 |
| XORTX Therapeutics | 3 |
| SciSparc | 3 |
SILO News
- 13 days ago - Silo Pharma’s QwikAgents expands AI agent platform with Nvidia model support - TheFly
- 13 days ago - Silo Pharma's QwikAgents Expands AI Agent Platform with NVIDIA Model Support and New Runtime Flexibility - GlobeNewsWire
- 25 days ago - Silo Pharma receives U.S. patent allowance for SPC-15 PTSD treatment - TheFly
- 25 days ago - Silo Pharma Receives U.S. Patent Allowance for SPC-15 PTSD Treatment, Expanding Intellectual Property Portfolio - GlobeNewsWire
- 4 weeks ago - Silo Pharma to Highlight Patented Nose-to-Brain Drug Delivery Technology for PTSD at 2026 Nasal Innovation Forum - GlobeNewsWire
- 7 weeks ago - Silo Pharma receives notice of allowance from CIPO for PTSD treatment - TheFly
- 7 weeks ago - Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment - GlobeNewsWire
- 2 months ago - Silo Pharma granted European patent covering PTSD therapy - TheFly